(Q44753948)

English

In vivo selection for human and murine hematopoietic cells transduced with a therapeutic MGMT lentiviral vector that inhibits HIV replication

scientific article published in February 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 December 2017

In vivo selection for human and murine hematopoietic cells transduced with a therapeutic MGMT lentiviral vector that inhibits HIV replication (English)

1 reference

Europe PubMed Central

6 December 2017

author name string

Brian M Davis

1

1 reference

Europe PubMed Central

6 December 2017

Laurent Humeau

2

1 reference

Europe PubMed Central

6 December 2017

Boro Dropulic

3

1 reference

Europe PubMed Central

6 December 2017

publication date

1 February 2004

1 reference

Europe PubMed Central

6 December 2017

Molecular Therapy

1 reference

Europe PubMed Central

6 December 2017

9

1 reference

Europe PubMed Central

6 December 2017

160-172

1 reference

Europe PubMed Central

6 December 2017

2

1 reference

Europe PubMed Central

6 December 2017

Antiretroviral-drug resistance among patients recently infected with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.003

7 January 2021

Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.003

7 January 2021

A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.003

7 January 2021

Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.003

7 January 2021

Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.003

7 January 2021

Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.003

7 January 2021

Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.003

7 January 2021

Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.003

7 January 2021

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.003

7 January 2021

Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.003

7 January 2021

Transfer and expression of the human multiple drug resistance gene into live mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.003

7 January 2021

In vivo selection of retrovirally transduced hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.003

7 January 2021

Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.003

7 January 2021

Characterization of the P140K, PVP(138-140)MLK, and G156A O6-methylguanine-DNA methyltransferase mutants: implications for drug resistance gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.003

7 January 2021

Lentiviral transduction of P140K MGMT into human CD34(+) hematopoietic progenitors at low multiplicity of infection confers significant resistance to BG/BCNU and allows selection in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.003

7 January 2021

Successful treatment of murine beta-thalassemia using in vivo selection of genetically modified, drug-resistant hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.003

7 January 2021

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

2 references

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.003

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Adapted NOD/SCID model supports development of phenotypically and functionally mature T cells from human umbilical cord blood CD34(+) cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.003

7 January 2021

Long-term exposure to lifelong therapies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YMTHE.2003.11.003

1 reference

Europe PubMed Central

6 December 2017

1 reference

Europe PubMed Central

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44753948&oldid=2100089516"